Company: INSP
Filing Date: 2025-11-17
Form Type: 8-K
Source: 0001609550-25-000055
Chunk: 0

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-11-17
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01. Other Events.

On November 6, 2025, Inspire Medical Systems, Inc. (“ Inspire” or the “ Company”) disclosed its expectation to release a significant portion of the valuation allowance on its U. S. deferred tax assets during the fourth quarter of fiscal 2025. The Company estimates that this release will result in an income tax benefit in the range of $90 million to $100 million for the year, which is expected to increase diluted earnings per share by approximately $3.00 to $3.30 for the same period.

Forward-Looking Statements